$9.67
-0.19-1.93%
가까이에: Nov 16, 4:00 PM EST
$9.67
N/A
시간외: 4:00 PM EST

Contineum Therapeutics (CTNM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $-0.49 | $-0.45 | -8.89 % |
| Q2 | Jul 30, 2026 | $-0.40 | $-0.45 | 11.1 % |
| Q1 | May 5, 2026 | $-0.39 | $-0.54 | 27.8 % |
| Q4 | Mar 5, 2026 | $-0.49 | $-0.43 | -14.0 % |
Quarterly Revenue (Billions)
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $0 | $2.26M | -100.0 % |
| Q4 | Mar 5, 2026 | $0 | $5.00M | -100.0 % |
| Q3 | Oct 30, 2025 | $0 | $5.00M | -100.0 % |
| Q2 | Aug 5, 2025 | $0 | $6.00M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.45 | $-0.45 | $-0.54 | $-0.43 |
| Actual | $-0.49 | $-0.40 | $-0.39 | $-0.49 |
| Surprise | -8.89% | +11.1% | +27.8% | -14.0% |
| Revenue | ||||
| Estimate | $2.3M | — | — | $5.0M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | — | — | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.50 | $-0.46 | $-0.44 | $-0.40 |
| Revenue | ||||
| Consensus | $5.0M | — | — | — |